| VCEL | Vericel Corp. | 0.147926% | 12,015,559.34 | 373,502 NS |
|---|
| MLYS | Mineralys Therapeutics, Inc. | 0.146628% | 11,910,064.32 | 439,648 NS |
|---|
| ALMS | Alumis, Inc. | 0.143842% | 11,683,786.74 | 530,358 NS |
|---|
| ZLAB | Zai Lab Ltd. | 0.142128% | 11,544,581.07 | 613,747 NS |
|---|
| NRIX | Nurix Therapeutics, Inc. | 0.137555% | 11,173,144 | 720,848 NS |
|---|
| STOK | Stoke Therapeutics, Inc. | 0.132798% | 10,786,737.28 | 331,288 NS |
|---|
| NTLA | Intellia Therapeutics, Inc. | 0.131841% | 10,709,020.34 | 835,337 NS |
|---|
| ANAB | AnaptysBio, Inc. | 0.131187% | 10,655,862.56 | 192,136 NS |
|---|
| RXRX | Recursion Pharmaceuticals, Inc. | 0.129255% | 10,498,960.99 | 3,419,857 NS |
|---|
| TYRA | Tyra Biosciences, Inc. | 0.128477% | 10,435,754.2 | 272,474 NS |
|---|
| RLAY | Relay Therapeutics, Inc. | 0.120079% | 9,753,646.7 | 980,266 NS |
|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 0.117655% | 9,556,750.4 | 687,536 NS |
|---|
| NVAX | Novavax, Inc. | 0.115958% | 9,418,907.96 | 1,157,114 NS |
|---|
| IOVA | Iovance Biotherapeutics, Inc. | 0.113174% | 9,192,763.71 | 2,619,021 NS |
|---|
| WVE | WaVe Life Sciences Ltd. | 0.104982% | 8,527,348.5 | 1,176,186 NS |
|---|
| IMCR | Immunocore Holdings plc | 0.102887% | 8,357,127.75 | 277,185 NS |
|---|
| NVCR | Novocure Ltd. | 0.102416% | 8,318,890.9 | 763,201 NS |
|---|
| Galapagos NV | Galapagos NV | 0.10042% | 8,156,790 | 271,893 NS |
|---|
| Grifols SA | Grifols SA | 0.096382% | 7,828,811.22 | 976,161 NS |
|---|
| BHVN | Biohaven Ltd. | 0.095564% | 7,762,346.1 | 917,535 NS |
|---|
| NUVB | Nuvation Bio, Inc. | 0.09485% | 7,704,359.52 | 1,795,888 NS |
|---|
| ATAI | AtaiBeckley, Inc. | 0.09414% | 7,646,637.18 | 2,160,067 NS |
|---|
| TSHA | Taysha Gene Therapies, Inc. | 0.092022% | 7,474,644.6 | 1,672,180 NS |
|---|
| SION | Sionna Therapeutics, Inc. | 0.091358% | 7,420,699.09 | 185,101 NS |
|---|
| TRVI | Trevi Therapeutics, Inc. | 0.089369% | 7,259,178.33 | 608,481 NS |
|---|
| Mesoblast Ltd. | Mesoblast Ltd. | 0.087127% | 7,076,999.34 | 460,143 NS |
|---|
| CRVS | Corvus Pharmaceuticals, Inc. | 0.085252% | 6,924,759.38 | 473,326 NS |
|---|
| OLMA | Olema Pharmaceuticals, Inc. | 0.084025% | 6,825,067.41 | 457,751 NS |
|---|
| RAPP | Rapport Therapeutics, Inc. | 0.083885% | 6,813,679.11 | 217,759 NS |
|---|
| QURE | uniQure NV | 0.083273% | 6,763,978.65 | 413,699 NS |
|---|
| GERN | Geron Corp. | 0.082787% | 6,724,523.47 | 4,513,103 NS |
|---|
| FTRE | Fortrea Holdings, Inc. | 0.080375% | 6,528,596.94 | 693,057 NS |
|---|
| VIR | Vir Biotechnology, Inc. | 0.077707% | 6,311,863.04 | 704,449 NS |
|---|
| XNCR | Xencor, Inc. | 0.076207% | 6,190,000.02 | 513,267 NS |
|---|
| ABCL | AbCellera Biologics, Inc. | 0.074418% | 6,044,756.78 | 1,732,022 NS |
|---|
| MBX | MBX Biosciences, Inc. | 0.073351% | 5,958,030.15 | 199,599 NS |
|---|
| MAZE | Maze Therapeutics, Inc. | 0.07274% | 5,908,389.6 | 197,936 NS |
|---|
| CDNA | CareDx, Inc. | 0.072214% | 5,865,700.96 | 337,886 NS |
|---|
| TBPH | Theravance Biopharma, Inc. | 0.070664% | 5,739,771.96 | 353,652 NS |
|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 0.070159% | 5,698,773.5 | 346,430 NS |
|---|
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | 0.068627% | 5,574,319.08 | 276,916 NS |
|---|
| JANX | Janux Therapeutics, Inc. | 0.067141% | 5,453,651.1 | 392,349 NS |
|---|
| PHVS | Pharvaris NV | 0.066763% | 5,422,898.25 | 191,961 NS |
|---|
| MNKD | MannKind Corp. | 0.066339% | 5,388,483.45 | 2,199,381 NS |
|---|
| ORIC | ORIC Pharmaceuticals, Inc. | 0.066203% | 5,377,426.74 | 424,422 NS |
|---|
| CSTL | Castle Biosciences, Inc. | 0.06519% | 5,295,164.95 | 215,689 NS |
|---|
| ANNX | Annexon, Inc. | 0.064991% | 5,278,977.36 | 952,884 NS |
|---|
| URGN | UroGen Pharma Ltd. | 0.063317% | 5,143,017.18 | 286,041 NS |
|---|
| KURA | Kura Oncology, Inc. | 0.062902% | 5,109,290.37 | 628,449 NS |
|---|
| INBX | Inhibrx Biosciences, Inc. | 0.062767% | 5,098,387.05 | 75,835 NS |
|---|
| Stevanato Group SpA | Stevanato Group SpA | 0.0627% | 5,092,876.25 | 370,391 NS |
|---|
| ABUS | Arbutus Biopharma Corp. | 0.062017% | 5,037,466.5 | 1,119,437 NS |
|---|
| SEPN | Septerna, Inc. | 0.059418% | 4,826,305.35 | 200,845 NS |
|---|
| ANRO | Alto Neuroscience, Inc. | 0.05886% | 4,780,978.96 | 212,677 NS |
|---|
| BCAX | Bicara Therapeutics, Inc. | 0.058001% | 4,711,244.85 | 236,865 NS |
|---|
| GHRS | GH Research plc | 0.057842% | 4,698,317.72 | 334,162 NS |
|---|
| AVBP | ArriVent Biopharma, Inc. | 0.057157% | 4,642,652.94 | 201,242 NS |
|---|
| CTMX | CytomX Therapeutics, Inc. | 0.057134% | 4,640,765.9 | 987,397 NS |
|---|
| CGEM | Cullinan Therapeutics, Inc. | 0.056582% | 4,595,926.09 | 323,429 NS |
|---|
| REPL | Replimune Group, Inc. | 0.053771% | 4,367,614.5 | 570,930 NS |
|---|
| PGEN | Precigen, Inc. | 0.052633% | 4,275,239.31 | 1,104,713 NS |
|---|
| ARVN | Arvinas, Inc. | 0.052604% | 4,272,860 | 403,100 NS |
|---|
| SVRA | Savara, Inc. | 0.052133% | 4,234,573.98 | 775,563 NS |
|---|
| IRWD | Ironwood Pharmaceuticals, Inc. | 0.050709% | 4,118,883.21 | 1,173,471 NS |
|---|
| PHAT | Phathom Pharmaceuticals, Inc. | 0.048822% | 3,965,658.95 | 356,945 NS |
|---|
| ZVRA | Zevra Therapeutics, Inc. | 0.047473% | 3,856,075.44 | 413,742 NS |
|---|
| CTKB | Cytek Biosciences, Inc. | 0.046738% | 3,796,332.62 | 868,726 NS |
|---|
| MGTX | MeiraGTx Holdings plc | 0.045913% | 3,729,368.38 | 430,643 NS |
|---|
| SPRY | ARS Pharmaceuticals, Inc. | 0.045812% | 3,721,134.12 | 463,404 NS |
|---|
| BIOA | BioAge Labs, Inc. | 0.045511% | 3,696,721.38 | 211,362 NS |
|---|
| SANA | Sana Biotechnology, Inc. | 0.043821% | 3,559,438.08 | 1,235,916 NS |
|---|
| RIGL | Rigel Pharmaceuticals, Inc. | 0.04362% | 3,543,078.24 | 131,031 NS |
|---|
| ZBIO | Zenas Biopharma, Inc. | 0.042346% | 3,439,646.55 | 175,941 NS |
|---|
| CMPS | Compass Pathways plc | 0.041676% | 3,385,189.5 | 612,150 NS |
|---|
| FULC | Fulcrum Therapeutics, Inc. | 0.040544% | 3,293,275.57 | 429,371 NS |
|---|
| OPK | OPKO Health, Inc. | 0.040457% | 3,286,164 | 2,882,600 NS |
|---|
| SLDB | Solid Biosciences, Inc. | 0.039583% | 3,215,174.4 | 446,552 NS |
|---|
| FDMT | 4D Molecular Therapeutics, Inc. | 0.038826% | 3,153,706.64 | 338,744 NS |
|---|
| Prothena Corp. plc | Prothena Corp. plc | 0.038694% | 3,142,952.28 | 323,349 NS |
|---|
| EBS | Emergent BioSolutions, Inc. | 0.038472% | 3,124,974.9 | 376,503 NS |
|---|
| MYGN | Myriad Genetics, Inc. | 0.036725% | 2,983,027.5 | 662,895 NS |
|---|
| ABSI | Absci Corp. | 0.036014% | 2,925,264 | 975,088 NS |
|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 0.035757% | 2,904,391.35 | 324,513 NS |
|---|
| CATX | Perspective Therapeutics, Inc. | 0.035601% | 2,891,728.2 | 693,460 NS |
|---|
| ACRS | Aclaris Therapeutics, Inc. | 0.035365% | 2,872,545 | 766,012 NS |
|---|
| ALT | Altimmune, Inc. | 0.035136% | 2,853,958.8 | 926,610 NS |
|---|
| VNDA | Vanda Pharmaceuticals, Inc. | 0.034457% | 2,798,812.58 | 405,038 NS |
|---|
| ALLO | Allogene Therapeutics, Inc. | 0.034412% | 2,795,195.68 | 1,145,572 NS |
|---|
| RGNX | REGENXBIO, Inc. | 0.034192% | 2,777,324.74 | 331,423 NS |
|---|
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | 0.033169% | 2,694,189.86 | 752,567 NS |
|---|
| PACB | Pacific Biosciences of California, Inc. | 0.032852% | 2,668,423.56 | 2,021,533 NS |
|---|
| LXEO | Lexeo Therapeutics, Inc. | 0.032326% | 2,625,745.78 | 457,447 NS |
|---|
| Alvotech SA | Alvotech SA | 0.03224% | 2,618,739.83 | 763,481 NS |
|---|
| CTNM | Contineum Therapeutics, Inc. | 0.032215% | 2,616,727.72 | 200,362 NS |
|---|
| ENTA | Enanta Pharmaceuticals, Inc. | 0.031904% | 2,591,473.92 | 205,184 NS |
|---|
| LCTX | Lineage Cell Therapeutics, Inc. | 0.03154% | 2,561,859.4 | 1,621,430 NS |
|---|
| LAB | Standard BioTools, Inc. | 0.031096% | 2,525,828.23 | 2,747,556 NS |
|---|
| ADCT | ADC Therapeutics SA | 0.031077% | 2,524,282.5 | 673,142 NS |
|---|
| DSGN | Design Therapeutics, Inc. | 0.030896% | 2,509,539.76 | 235,859 NS |
|---|
| PSNL | Personalis, Inc. | 0.030832% | 2,504,384.61 | 393,153 NS |
|---|